Single User License
INR 170050
Site License
INR 340100
Corporate User License
INR 510150

Service Tax Additional

select a format
Price

Single User License
USD 2500
Site License
USD 5000
Corporate User License
USD 7500

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Ken Research completed the report successfully with tough deadline and large requirement. Really appreciate it... "Sales Manager, Largest India Aesthetic Laser Manufacturer"

We found the report really useful in understanding the complex Indian market and it provided lots of high quality insights. On the basis of this we commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights.... "Owner, Therefore Consulting UK"


Vestibular Diseases Global Clinical Trials Review, H2

Vestibular Diseases Global Clinical Trials Review, H2


  Request for Sample Report

Executive Summary

Vestibular Diseases Global Clinical Trials Review, H2, 2015

GlobalData's clinical trial report, "Vestibular Diseases Global Clinical Trials Review, H2, 2015" provides an overview of Vestibular Diseases clinical trials scenario. This report provides top line data relating to the clinical trials on Vestibular Diseases. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database-Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

The report provides a snapshot of the global clinical trials landscape

Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

The Report provides enrollment trends for the past five years

Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons To Buy

Assists in formulating key business strategies with regards to investment

Helps in identifying prominent locations for conducting clinical trials which saves time and cost

Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

Supports understanding of trials count and enrollment trends by country in global therapeutics market

Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Vestibular Diseases 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Countries Contributing to Clinical Trials in Middle East and Africa 13

Top Countries Contributing to Clinical Trials in Central and South America 14

Clinical Trials by G7 Countries: Proportion of Vestibular Diseases to Ear Nose Throat Disorders Clinical Trials 15

Clinical Trials by Phase in G7 Countries 16

Clinical Trials in G7 Countries by Trial Status 17

Clinical Trials by E7 Countries: Proportion of Vestibular Diseases to Ear Nose Throat Disorders Clinical Trials 18

Clinical Trials in E7 Countries by Trial Status 19

Clinical Trials by Phase 20

In Progress Trials by Phase 21

Clinical Trials by Trial Status 22

Clinical Trials by End Point Status 23

Unaccomplished Trials of Vestibular Diseases 24

Subjects Recruited Over a Period of Time 26

Clinical Trials by Sponsor Type 27

Prominent Sponsors 28

Top Companies Participating in Vestibular Diseases Therapeutics Clinical Trials 29

Prominent Drugs 30

Clinical Trial Profiles 31

Clinical Trial Overview of Top Companies 31

Sensorion S.A. 31

Clinical Trial Overview of Sensorion S.A. 31

SK Chemicals Co., Ltd. 32

Clinical Trial Overview of SK Chemicals Co., Ltd. 32

Neocutis, Inc. 33

Clinical Trial Overview of Neocutis, Inc. 33

Laboratoires Pierre Fabre SA 34

Clinical Trial Overview of Laboratoires Pierre Fabre SA 34

Fuerza Aerea de Chile 35

Clinical Trial Overview of Fuerza Aerea de Chile 35

Apsen Farmaceutica SA 36

Clinical Trial Overview of Apsen Farmaceutica SA 36

Clinical Trial Overview of Top Institutes / Government 37

Asan Medical Center 37

Clinical Trial Overview of Asan Medical Center 37

Centre Hospitalier Universitaire de Caen 38

Clinical Trial Overview of Centre Hospitalier Universitaire de Caen 38

Federal University of Sao Paulo 39

Clinical Trial Overview of Federal University of Sao Paulo 39

Hospital do Servidor Publico Estadual 40

Clinical Trial Overview of Hospital do Servidor Publico Estadual 40

Ludwig Maximilians Universitat Munich 41

Clinical Trial Overview of Ludwig Maximilians Universitat Munich 41

McGill University Health Center 42

Clinical Trial Overview of McGill University Health Center 42

Norwegian University of Science and Technology 43

Clinical Trial Overview of Norwegian University of Science and Technology 43

Schepens Eye Research Institute 44

Clinical Trial Overview of Schepens Eye Research Institute 44

Universite de Montreal 45

Clinical Trial Overview of Universite de Montreal 45

University Health Network 46

Clinical Trial Overview of University Health Network 46

Five Key Clinical Profiles 47

Appendix 65

Abbreviations 65

Definitions 65

Research Methodology 66

Secondary Research 66

About GlobalData 67

Contact Us 67

Disclaimer 67

Source 68

List of Figures

Vestibular Diseases Therapeutics, Global, Clinical Trials by Region (%), 2015* 7

Vestibular Diseases Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Vestibular Diseases Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Vestibular Diseases Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11

Vestibular Diseases Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12

Vestibular Diseases Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015* 14

Proportion of Vestibular Diseases to Ear Nose Throat Disorders Clinical Trials, G7 Countries (%), 2015* 15

Vestibular Diseases Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Vestibular Diseases Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Vestibular Diseases to Ear Nose Throat Disorders Clinical Trials, E7 Countries (%), 2015* 18

Vestibular Diseases Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 19

Vestibular Diseases Therapeutics, Global, Clinical Trials by Phase (%), 2015* 20

Vestibular Diseases Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 21

Vestibular Diseases Therapeutics, Global, Clinical Trials by Trial Status, 2015* 22

Vestibular Diseases Therapeutics Clinical Trials, Global, by End Point Status, 2015* 23

Vestibular Diseases Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 26

Vestibular Diseases Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 27

Vestibular Diseases Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 28

Vestibular Diseases Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29

Vestibular Diseases Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30

GlobalData Methodology 66

List of Tables

Vestibular Diseases Therapeutics, Global, Clinical Trials by Region, 2015* 7

Vestibular Diseases Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Vestibular Diseases Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Vestibular Diseases Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 10

Vestibular Diseases Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11

Vestibular Diseases Therapeutics Clinical Trials, North America, Top Countries, 2015* 12

Vestibular Diseases Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13

Vestibular Diseases Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14

Proportion of Vestibular Diseases to Ear Nose Throat Disorders Clinical Trials, G7 Countries (%), 2015* 15

Vestibular Diseases Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Vestibular Diseases Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Vestibular Diseases to Ear Nose Throat Disorders Clinical Trials, E7 Countries (%), 2015* 18

Vestibular Diseases Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 19

Vestibular Diseases Therapeutics, Global, Clinical Trials by Phase, 2015* 20

Vestibular Diseases Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 21

Vestibular Diseases Therapeutics, Global, Clinical Trials by Trial Status, 2015* 22

Vestibular Diseases Therapeutics Clinical Trials, Global, by End Point Status, 2015* 23

Vestibular Diseases Therapeutics, Global, Withdrawn Clinical Trials, 2015* 24

Vestibular Diseases Therapeutics, Global, Terminated Clinical Trials, 2015* 25

Vestibular Diseases Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 26

Vestibular Diseases Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 27

Vestibular Diseases Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 28

Vestibular Diseases Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29

Vestibular Diseases Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30

Vestibular Diseases Therapeutics Clinical Trials Market, Global, Clinical Trials by Sensorion S.A., 2015* 31

Vestibular Diseases Therapeutics Clinical Trials Market, Global, Clinical Trials by SK Chemicals Co., Ltd., 2015* 32

Vestibular Diseases Therapeutics Clinical Trials Market, Global, Clinical Trials by Neocutis, Inc., 2015* 33

Vestibular Diseases Therapeutics Clinical Trials Market, Global, Clinical Trials by Laboratoires Pierre Fabre SA, 2015* 34

Vestibular Diseases Therapeutics Clinical Trials Market, Global, Clinical Trials by Fuerza Aerea de Chile, 2015* 35

Vestibular Diseases Therapeutics Clinical Trials Market, Global, Clinical Trials by Apsen Farmaceutica SA, 2015* 36

Vestibular Diseases Therapeutics Clinical Trials Market, Global, Clinical Trials by Asan Medical Center, 2015* 37

Vestibular Diseases Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Hospitalier Universitaire de Caen, 2015* 38

Vestibular Diseases Therapeutics Clinical Trials Market, Global, Clinical Trials by Federal University of Sao Paulo, 2015* 39

Vestibular Diseases Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital do Servidor Publico Estadual, 2015* 40

Vestibular Diseases Therapeutics Clinical Trials Market, Global, Clinical Trials by Ludwig Maximilians Universitat Munich, 2015* 41

Vestibular Diseases Therapeutics Clinical Trials Market, Global, Clinical Trials by McGill University Health Center, 2015* 42

Vestibular Diseases Therapeutics Clinical Trials Market, Global, Clinical Trials by Norwegian University of Science and Technology, 2015* 43

Vestibular Diseases Therapeutics Clinical Trials Market, Global, Clinical Trials by Schepens Eye Research Institute, 2015* 44

Vestibular Diseases Therapeutics Clinical Trials Market, Global, Clinical Trials by Universite de Montreal, 2015* 45

Vestibular Diseases Therapeutics Clinical Trials Market, Global, Clinical Trials by University Health Network, 2015* 46

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Sensorion S.A.

SK Chemicals Co., Ltd.

Neocutis, Inc.

Laboratoires Pierre Fabre SA

Fuerza Aerea de Chile

Apsen Farmaceutica SA

Vestibular Diseases Clinical Trials, Phase, Completed, Ongoing, Planned, End Points, Trial Locations, Trial Designs, Subjects Recruited, Safety, Efficacy, Bioequivalence, Pharmacokinetics, Pharmacodynamic, Sponsor, Collaborator, CRO's, Terminated, Suspended and Withdrawn trials of Vestibular Diseases, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas M. D. Anderson Cancer Center, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, University of Pennsylvania.


Related Products in vertical
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com